Literature DB >> 2083874

Heparin structure.

B Casu1.   

Abstract

Heparins used in therapy are largely constituted by sequences of the trisulfated disaccharide L-iduronic acid-2-sulfate----D-glucosamine-N,6-disulfate. These regular sequences are interrupted by undersulfated (occasionally, oversulfated) sequences containing D-glucuronic acid and N-acetylated D-glucosamine. Different heparin sequences are binding domains for heparin cofactors and plasma proteins. The active site for antithrombin is a specific pentasaccharide sequence containing 3-O-sulfated D-glucosamine. Heparin cofactor-II binds, less specifically, mostly to the regular sequences. The conformational flexibility of iduronic acid residues contributes to the binding versatility and to the 'biological reactivity' of heparin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2083874     DOI: 10.1159/000216162

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  6 in total

1.  2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection.

Authors:  Atsuko Hayashida; Shiro Amano; Richard L Gallo; Robert J Linhardt; Jian Liu; Pyong Woo Park
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

2.  Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin.

Authors:  J Ermolieff; J Duranton; M Petitou; J G Bieth
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

3.  Mass balance analysis of contaminated heparin product.

Authors:  Zhenling Liu; Zhongping Xiao; Sayaka Masuko; Wenjing Zhao; Eric Sterner; Vinod Bansal; Jawed Fareed; Jonathan Dordick; Fuming Zhang; Robert J Linhardt
Journal:  Anal Biochem       Date:  2010-09-17       Impact factor: 3.365

4.  Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes.

Authors:  Sheng-Li Ji; Hui-Fei Cui; Feng Shi; Yan-Qing Chi; Ji-Chao Cao; Mei-Yu Geng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

5.  Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.

Authors:  D Coltrini; M Rusnati; G Zoppetti; P Oreste; G Grazioli; A Naggi; M Presta
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

Review 6.  Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review.

Authors:  Sarah Mousavi; Mandana Moradi; Tina Khorshidahmad; Maryam Motamedi
Journal:  Adv Pharmacol Sci       Date:  2015-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.